SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,033,268 | +43.5% | 37,478 | +56.4% | 0.00% | – |
| Q2 2023 | $720,268 | +22.2% | 23,961 | +47.3% | 0.00% | – |
| Q1 2023 | $589,535 | +69.0% | 16,272 | +66.4% | 0.00% | – |
| Q4 2022 | $348,853 | +64.6% | 9,780 | +55.9% | 0.00% | – |
| Q3 2022 | $212,000 | -58.5% | 6,274 | -64.5% | 0.00% | – |
| Q2 2022 | $511,000 | -82.1% | 17,668 | -80.0% | 0.00% | -100.0% |
| Q1 2022 | $2,854,000 | -14.8% | 88,293 | -23.1% | 0.00% | 0.0% |
| Q4 2021 | $3,349,000 | +1250.4% | 114,829 | +1134.7% | 0.00% | – |
| Q3 2021 | $248,000 | -55.2% | 9,300 | -48.3% | 0.00% | – |
| Q2 2021 | $554,000 | -30.4% | 18,000 | -40.8% | 0.00% | – |
| Q1 2021 | $796,000 | -39.9% | 30,402 | -42.2% | 0.00% | – |
| Q4 2020 | $1,325,000 | +22.5% | 52,632 | +15.4% | 0.00% | -100.0% |
| Q4 2019 | $1,082,000 | +403.3% | 45,616 | +483.0% | 0.00% | – |
| Q3 2019 | $215,000 | -22.9% | 7,824 | -7.1% | 0.00% | – |
| Q2 2019 | $279,000 | -78.3% | 8,425 | -77.0% | 0.00% | -100.0% |
| Q1 2019 | $1,285,000 | -45.5% | 36,645 | -48.4% | 0.00% | -60.0% |
| Q4 2018 | $2,359,000 | +148.1% | 70,991 | +275.9% | 0.01% | +150.0% |
| Q3 2018 | $951,000 | +17.0% | 18,887 | +39.1% | 0.00% | 0.0% |
| Q2 2018 | $813,000 | -45.8% | 13,579 | -63.8% | 0.00% | -60.0% |
| Q3 2017 | $1,501,000 | +544.2% | 37,534 | +595.7% | 0.01% | +400.0% |
| Q2 2017 | $233,000 | +56.4% | 5,395 | -51.3% | 0.00% | 0.0% |
| Q4 2015 | $149,000 | -60.4% | 11,083 | -64.4% | 0.00% | -66.7% |
| Q1 2015 | $376,000 | -65.4% | 31,113 | -68.7% | 0.00% | -78.6% |
| Q2 2014 | $1,087,000 | +391.9% | 99,268 | +301.4% | 0.01% | +600.0% |
| Q1 2014 | $221,000 | – | 24,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |